Exploring New Strategies for the Management of Nonalcoholic Steatohepatitis: NOT a Trivial Pursuit

Nov 12 2023
Room 210 - Hynes Convention Center
12:30 - 2:00 PM EST

Description

Supported by: Madrigal

Organized by: Medscape Education

Presenters:

Manal F. Abdelmalek, MD​

Stephen A. Harrison, MD

Mary E. Rinella, MD

The incidence of nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction-associated steatohepatitis (MASH), continues to rise globally along with an increase in obesity, type 2 diabetes, and other metabolic disorders. Patients at risk of MASH greatly benefit from early identification and intervention. Join us at this interactive, case-based symposium where you can see how your case management strategies compare with those of your peers. Don’t miss out!

Learning Objectives: Upon completion of this activity, participants will:

  1. Have increased knowledge regarding the prevalence and risk factors for NASH, and clinical data for new and emerging treatments for NASH
  2. Have greater competence related to evaluating risk of fibrotic disease and NASH in patients with risk factors
  3. Demonstrate greater confidence in their ability to Include new and emerging NASH treatments into treatment strategies

CME Hours: Maximum of 1.25 AMA PRA Category 1 Credit(s)™

For more information and to register, visit: https://www.medscape.org/symposium/nash-fall-2023